Records 1 - 11
| Mutations of key driver genes in colorectal cancer progression and metastasis.
Cancer metastasis reviews 2018 Jan .
Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong
| Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
World journal of gastroenterology 2016 Aug 22 (30): 6944-54.
Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco
| Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Jul .
Mei Z, Duan C, Li C, Cui L, Ogino
| PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2015 Dec .
Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi
| The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64.
Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M
| Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: meta-analysis, co-occurrence and ethnic variation.
International journal of cancer. Journal international du cancer 2014 Mar 134 (5): 1232-8.
Chong Mei-Ling, Loh Marie, Thakkar Bhavin, Pang Brendan, Iacopetta Barry, Soong Rich
| Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.
Archives of medical science : AMS 2014 Feb 10 (1): 1-9.
Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao
| PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.
Journal of cancer research and clinical oncology 2013 May 139 (5): 891-900.
Wu Shuangjie, Gan Yu, Wang Xinhai, Liu Jun, Li Mengjun, Tang Yif
| Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis.
International journal of cancer. Journal international du cancer 2013 Mar .
Yang ZY, Wu XY, Huang YF, Di MY, Zheng DY, Chen JZ, Ding H, Mao C, Tang JL
| PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Jun 23 (6): 1518-25.
Mao C, Yang Z Y, Hu X F, Chen Q, Tang J
| Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.
OncoTargets and therapy 0 8 3265-3276.
Tang Jie-Ting, Wang Zhen-Hua, Fang Jing-Yu